Schon Eric A, DiMauro Salvatore
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Curr Med Chem. 2003 Dec;10(23):2523-33. doi: 10.2174/0929867033456503.
Although great progress has been made in our understanding of the molecular bases of mitochondrial disorders due to defects in the respiratory chain, little exists in the way of rational therapy. Possible therapeutic approaches include: palliative therapy; removal of noxious metabolites; administration of artificial electron acceptors, metabolites, and free radical scavengers; genetic counseling; and gene therapy. There has been progress with each of these approaches, although much work remains to be done. Finally, a novel approach to treating a specific mitochondrial disorder, MELAS, is presented.
尽管我们在理解由于呼吸链缺陷导致的线粒体疾病的分子基础方面取得了巨大进展,但合理的治疗方法却很少。可能的治疗方法包括:姑息治疗;清除有害代谢产物;给予人工电子受体、代谢产物和自由基清除剂;遗传咨询;以及基因治疗。这些方法都取得了进展,尽管仍有许多工作要做。最后,本文介绍了一种治疗特定线粒体疾病——线粒体脑肌病伴乳酸血症和卒中样发作(MELAS)的新方法。